BofA: We're Upgrading Biocryst Pharmaceuticals
April 20, 2015 at 09:33 AM EDT
In a report published Monday, analysts at Bank of America upgraded BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) to Neutral. The price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.